VJ - Antifungals Flashcards
What are Fungi? (4)
- Eukaryotes (unicellular and multicellular, cell nucleus, etc.)
- Heterotrophs except with lichen (algae/cyanobacteria)
- Mostly opportunistic (secondary) infection
- Cause superficial, (sub)cutaneous and systemic (tissues/organs) = mycoses
What are the 3 problematic classes of fungi for humans?
- Dermatophytes
- Yeast
- Moulds
What are characteristics of Dermatophytes? (2)
- Commensals that metabolize keratin
- Cause common superficial diseases (e.g., ringworm, athlete’s foot, jock itch)
What are characteristics of Yeast? (4)
- Unicellular, reproduces by fission or budding
- Often commensal (pharynx, GI tract, vagina)
- Diseases: e.g., Candida (C. auris, C. albicans) and Cryptococcus (C. neoformans)
- Causes mucosal infections (e.g., thrush) and systemic infections (e.g., meningitis)
What are characteristics of Moulds? (3)
- Multicellular, form colonies, reproduce through sporulation
- Commonly found in soil and organic matter
- Diseases: e.g., Aspergillosis (from Aspergillus sp.) - often begins in airways, can spread systemically
How are fungi becoming a growing problem? (3)
- Usually in immunocompromised (AIDS, immunosuppression, radiotherapy, organ transplants, etc.)
- Hospital acquired infections: pregnancy, diabetes, antibiotic treatment
- Becoming increasingly resistant to antifungals
What makes fungi different to other eukaryotes?
Cell wall containing glucans and chitin, as well as a cell membrane containing ergosterol
Why are fungal infections challenging to treat? (3)
- Fungi grow slowly and infect poorly penetrated tissues
- Require prolonged treatment due to resistance
- Have a unique cell wall with glucans, chitin, and a membrane with ergosterol
What is the difference between fungistatic and fungicidal antifungals?
Fungistatic: Inhibits fungal growth
Fungicidal: Kills fungal cells
What are major sites of action for antifungal drugs? (5)
1) Inhibition of nucleic acid synthesis
- Flucytosine
2) Inhibition of proteins synthesis
Sordarins
- AzasordarinsStructure and synthesis of fungal cell walls
3) Disruption of microtubules and inhibition of mitosis
- Griseofulvin
4) Disruption of cell wall
- Inhibitors of glucan synthesis (Echinocandins)
- Inhibitors of chitin synthesis (Nikkomycin)
5) Disruption of cell membrane
- Inhibitors of ergosterol synthesis (Azoles/Allylamines)
- Direct membrane damage (Polyenes)
Describe the fungal cell wall structure (2)
Inner layer: β‐1,3‐glucan, β‐1,6‐glucan, chitin
Outer layer: mannose-proteins (involved in cell adhesion, immune evasion)
What are the functions of the fungal cell wall? (4)
- Offers environmental protection against osmotic forces
- Involved in morphogenesis (cell division, budding, filamentous growth)
- Prevents leakage of mannose-proteins by providing an anchoring point
- Mannose-proteins aid in cell adhesion, structure, and immune evasion (e.g., dectin-1 in Candida albicans)
hat is the role of Uracil diphosphate (UDP) in fungal cell wall synthesis?
UDP is a carrier molecule for glucose and N-acetyl glucosamine
It activates the following synthases:
* Chitin synthase
* β-1,3-glucan synthase (FKS1p and FKS2p)
* β-1,6-glucan synthase
What are Echinocandins and their role in antifungal treatment? (5)
Echinocandins are β-1,3-glucan synthesis inhibitors (natural and semi-synthetic)
- Cyclic hexapeptides that inhibit β-1,3-glucan synthase (FKS1p subunit) via non-competitive inhibition (binding site unresolved)
- Known as the “penicillin of antifungals,” they are fungistatic and fungicidal
- Effective against Candida and Aspergillus infections
- Good distribution in tissues, including the brain; however, they have poor bioavailability, requiring intravenous administration
What is Nikkomycin Z and its role in antifungal treatment? (3)
Nikkomycin Z is a chitin synthesis inhibitor that competitively inhibits chitin synthase
- It is believed to enter cells via a peptide endocytosis mechanism
- Currently used in veterinary settings but has not advanced beyond Phase I clinical trials in humans due to high costs